Growth characteristics of the veterinary vaccine candidate ChimeriVax™‐West Nile (WN) virus in Aedes and Culex mosquitoes
- 27 August 2003
- journal article
- Published by Wiley in Medical and Veterinary Entomology
- Vol. 17 (3) , 235-243
- https://doi.org/10.1046/j.1365-2915.2003.00438.x
Abstract
In 1999 West Nile (WN) virus was introduced to North America where this flavivirus has spread rapidly among wildlife (especially birds) transmitted by various species of mosquitoes (Diptera: Culicidae). Increasing numbers of cases and deaths among humans, horses and other domestic animals require development of effective vaccines. ‘ChimeriVax™‐West Nile(vet)’ is being developed for use as a veterinary vaccine to protect against WN infection. This chimeric virus contains the pre‐membrane (prM) and envelope (E) genes from the wild‐type WN NY99 virus (isolated from a flamingo in New York zoo during the 1999 WN epidemic) in the backbone of yellow fever (YF) 17D vaccine virus. Replication kinetics of ChimeriVax™‐WN(vet) virus were evaluated in mosquito cell culture (Aedes albopictus C6/36), in WN vector mosquitoes [Culex tritaeniorhynchus Giles, Cx. nigripalpus Theobald and Cx. quinquefasciatus Say (Diptera: Culicidae)] and in YF vectors [Aedes aegypti (L) and Ae. albopictus (Skuse)], to determine whether these mosquitoes become infected through feeding on a viraemic vaccine, and their potential infectivity to transmit the virus. Growth of ChimeriVax™‐WN(vet) virus was found to be restricted in mosquitoes, compared to WN virus in Ae. albopictus C6/36 cells. When inoculated intrathoracically, ChimeriVax™‐WN(vet) and YF 17D viruses did not replicate in Cx. tritaeniorhynchus or Cx. nigripalpus; replication was very restricted compared to the wild‐type WN virus in Cx. quinquefasciatus, Ae. aegypti and Ae. albopictus. When fed on hanging drops with ChimeriVax™‐WN(vet) virus (7.7 log10 PFU/mL), none of the Culex mosquitoes became infected; one Ae. albopictus and 10% of the Ae. aegypti became infected, but the titre was very low and virus did not disseminate to head tissue. ChimeriVax™‐WN(vet) virus had a replication profile similar to that of the attenuated vaccine virus YF 17D, which is not transmitted by mosquitoes. These results suggest that the natural mosquito vectors of WN and YF viruses, which may incidentally take a bloodmeal from a vaccinated host, will not become infected with ChimeriVax™‐WN(vet) virus.Keywords
This publication has 32 references indexed in Scilit:
- West Nile virus Epidemic in Horses, Tuscany Region, ItalyEmerging Infectious Diseases, 2002
- Efficacy of Killed Virus Vaccine, Live Attenuated Chimeric Virus Vaccine, and Passive Immunization for Prevention ofWest Nile virusEncephalitis in Hamster ModelEmerging Infectious Diseases, 2002
- Mouse Neuroinvasive Phenotype of West Nile Virus Strains Varies Depending upon Virus GenotypeVirology, 2002
- Experimental Infection of Horses with West Nile virusEmerging Infectious Diseases, 2002
- West Nile Virus Activity in the United States, 2001Viral Immunology, 2001
- West Nile Virus Infection in Birds and Mosquitoes, New York State, 2000Emerging Infectious Diseases, 2001
- West Nile Virus Recombinant DNA Vaccine Protects Mouse and Horse from Virus Challenge and Expresses In Vitro a Noninfectious Recombinant Antigen That Can Be Used in Enzyme-Linked Immunosorbent AssaysJournal of Virology, 2001
- Origin of the West Nile Virus Responsible for an Outbreak of Encephalitis in the Northeastern United StatesScience, 1999
- Host-Feeding Patterns of Aedes albopictus (Diptera: Culicidae) at a Temperate North American SiteJournal of Medical Entomology, 1993
- Vector Competence of Culex Tritaeniorhynchus (Diptera: Culicidae) for West Nile Virus1Journal of Medical Entomology, 1980